Weigh at least 110 pounds
Mounjaro (tirzepatide) uniquely targets both GLP-1 and GIP receptors, potentially offering more substantial weight reduction and improved glycemic control compared to other GLP-1RAs that only target the GLP-1 receptor, such as Ozempic (semaglutide)
The science vs
Its difficult to generalize because insurance coverage varies and coverage for weight-loss medications often depends on the insurance plan, employer, and medical necessity, with people sometimes needing to meet specific criteria (like a certain body mass index) to qualify
Although GLP-1 drugs are generally considered safe to use, its recommended to avoid them if you have or had: Personal or family history of thyroid cancer Family history of multiple endocrine neoplasia 2 (MEN-2) Pancreatitis Used other anti-obesity medications These medications can aggravate the above conditions, which may lead to serious health complications
We recommend that you read labels, warnings, and directions of all products before use and not rely solely on the information provided by HiLife Vitamins
